Recursion Pharmaceuticals Stock Market Value
| RXRX Stock | USD 8.59 0.20 2.28% |
| Symbol | Recursion |
Recursion Pharmaceuticals Price To Book Ratio
Is Recursion Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Recursion Pharmaceuticals. If investors know Recursion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Recursion Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.58) | Revenue Per Share 0.214 | Quarterly Revenue Growth (0.20) | Return On Assets (0.32) | Return On Equity (0.69) |
The market value of Recursion Pharmaceuticals is measured differently than its book value, which is the value of Recursion that is recorded on the company's balance sheet. Investors also form their own opinion of Recursion Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Recursion Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Recursion Pharmaceuticals' market value can be influenced by many factors that don't directly affect Recursion Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Recursion Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Recursion Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Recursion Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Recursion Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Recursion Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Recursion Pharmaceuticals.
| 04/09/2024 |
| 05/09/2024 |
If you would invest 0.00 in Recursion Pharmaceuticals on April 9, 2024 and sell it all today you would earn a total of 0.00 from holding Recursion Pharmaceuticals or generate 0.0% return on investment in Recursion Pharmaceuticals over 30 days. Recursion Pharmaceuticals is related to or competes with Absci Corp, Affimed NV, Sana Biotechnology, Relay TherapeuticsInc, Immix Biopharma, Cns Pharmaceuticals, and Hepion Pharmaceuticals. Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by i... More
Recursion Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Recursion Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Recursion Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.51 | |||
| Information Ratio | (0.0003) | |||
| Maximum Drawdown | 37.88 | |||
| Value At Risk | (7.37) | |||
| Potential Upside | 10.4 |
Recursion Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Recursion Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Recursion Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Recursion Pharmaceuticals historical prices to predict the future Recursion Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.018 | |||
| Jensen Alpha | 0.0975 | |||
| Total Risk Alpha | (0.67) | |||
| Sortino Ratio | (0.0003) | |||
| Treynor Ratio | (0.28) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Recursion Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Recursion Pharmaceuticals Backtested Returns
Recursion Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0145, which implies the firm had a -0.0145% return per unit of risk over the last 3 months. Recursion Pharmaceuticals exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Recursion Pharmaceuticals' Coefficient Of Variation of 6868.51, semi deviation of 5.42, and Risk Adjusted Performance of 0.018 to confirm the risk estimate we provide. The company holds a Beta of -0.27, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Recursion Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Recursion Pharmaceuticals is likely to outperform the market. Recursion Pharmaceuticals has an expected return of -0.0865%. Please make sure to check Recursion Pharmaceuticals coefficient of variation, maximum drawdown, skewness, as well as the relationship between the total risk alpha and downside variance , to decide if Recursion Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.76 |
Almost perfect reverse predictability
Recursion Pharmaceuticals has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Recursion Pharmaceuticals time series from 9th of April 2024 to 24th of April 2024 and 24th of April 2024 to 9th of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Recursion Pharmaceuticals price movement. The serial correlation of -0.76 indicates that around 76.0% of current Recursion Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.76 | |
| Spearman Rank Test | -0.62 | |
| Residual Average | 0.0 | |
| Price Variance | 0.16 |
Recursion Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Recursion Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Recursion Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Recursion Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Recursion Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Recursion Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Recursion Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Recursion Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Recursion Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Recursion Pharmaceuticals Lagged Returns
When evaluating Recursion Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Recursion Pharmaceuticals stock have on its future price. Recursion Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Recursion Pharmaceuticals autocorrelation shows the relationship between Recursion Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Recursion Pharmaceuticals.
Regressed Prices |
| Timeline |
Recursion Pharmaceuticals Investors Sentiment
The influence of Recursion Pharmaceuticals' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Recursion. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Recursion Pharmaceuticals' public news can be used to forecast risks associated with an investment in Recursion. The trend in average sentiment can be used to explain how an investor holding Recursion can time the market purely based on public headlines and social activities around Recursion Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Recursion Pharmaceuticals' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Recursion Pharmaceuticals' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Recursion Pharmaceuticals' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Recursion Pharmaceuticals.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Recursion Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Recursion Pharmaceuticals' short interest history, or implied volatility extrapolated from Recursion Pharmaceuticals options trading.
Currently Active Assets on Macroaxis
When determining whether Recursion Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Recursion Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Recursion Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Recursion Pharmaceuticals Stock:Check out Recursion Pharmaceuticals Correlation, Recursion Pharmaceuticals Volatility and Recursion Pharmaceuticals Alpha and Beta module to complement your research on Recursion Pharmaceuticals. For more information on how to buy Recursion Stock please use our How to Invest in Recursion Pharmaceuticals guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Recursion Stock analysis
When running Recursion Pharmaceuticals' price analysis, check to measure Recursion Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Recursion Pharmaceuticals is operating at the current time. Most of Recursion Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Recursion Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Recursion Pharmaceuticals' price. Additionally, you may evaluate how the addition of Recursion Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |
Recursion Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.